Skip to content
Back to browse
KIDNEY Publication-derived

Kidney Organoids for Disease Modelling with Vasculature

Source Homan et al., 2019 · Wyss Institute for Biologically Inspired Engineering, Harvard University; Renal Division, Brigham and Women's Hospital · 10.1038/s41592-019-0325-y

Authors: Kimberly A. Homan, Navin Gupta, Katharina T. Kroll, David B. Kolesky, Mark Skylar-Scott, Tomoya Miyoshi, Donald Mau, M. Todd Valerius, Thomas Ferrante, Joseph V. Bonventre, Jennifer A. Lewis, Ryuji Morizane Duration: 21 days 5 phases Cell source: Human iPSC (BJFF line) and Human ESC (H9)

Abstract

This protocol describes an in vitro method for culturing kidney organoids derived from human pluripotent stem cells on millifluidic chips under controlled fluidic shear stress (FSS). The system greatly expands endogenous endothelial progenitor cell pools and generates vascularized kidney organoids with perfusable lumens, mature podocytes, and tubular compartments, mimicking early-stage embryonic kidney development.

Cell source
Human iPSC (BJFF line) and Human ESC (H9)
Application
Disease modeling, developmental study

Protocol overview

26 steps across 5 phases

Phase 1 · Millifluidic chip fabrication and ECM preparation Before organoid seeding
  1. a Prepare silicone ink for 3D printing
  2. b 3D print perfusion chip gasket
  3. c Cure and sterilize printed chip
  4. d Prepare gelatin solution for ECM
  5. e Prepare fibrinogen solution for ECM
  6. f Prepare transglutaminase (TG) solution for ECM
  7. g Prepare CaCl₂ and thrombin stock solutions for ECM
  8. h Mix ECM components before gelation
  9. i Rapidly mix ECM with thrombin and cast on chip
  10. j Incubate chip with cured ECM
Phase 2 · hPSC culture and organoid preparation Days 0-14
  1. a Maintain hPSCs in feeder-free culture
  2. b Differentiate hPSCs into metanephric mesenchyme
  3. c Form pretubular aggregates in suspension culture
Phase 3 · Organoid seeding and chip assembly Day 14 (chip seeding)
  1. a Seed pretubular aggregates onto ECM on chip
  2. b Assemble chip housing and tubing
  3. c Connect perfusion circuit and fill chip with media
  4. d Equilibrate media reservoir and initiate low-flow perfusion
Phase 4 · Flow perfusion culture and organoid maturation Days 14-21 (chip culture)
  1. a Transition to high fluidic shear stress (FSS) perfusion
  2. b Change media every 2-3 days
  3. c Continue high-flow culture through Day 21
Phase 5 · Analysis and assessment (Day 21) Day 21
  1. a Prepare organoids for immunostaining
  2. b Perform immunostaining with primary antibodies
  3. c Perform secondary antibody staining and counterstaining
  4. d Image organoids using confocal microscopy
  5. e Analyze vasculature using Angiotool
  6. f Quantify tubule-vascular associations using Imaris

Full SOP

Full SOPs need an account and a plan

Create an account, then get free Academic access (for verified academics) or choose a plan. Plans include step-by-step procedures, reagent concentrations, QC checklists and batch record templates.

Create an account

Already registered? Log in

Attribution

This SOP was written by Organthis based on the published method in Homan et al., 2019. Once the originating laboratory has confirmed it, the SOP is marked Verified.

Something wrong with this entry? Report an issue with this protocol

Need a commercial licence?
Use this protocol in your therapeutic or diagnostic pipeline.